Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
On (b)(6) 2019, the patient underwent an endovascular treatment for a right internal iliac artery aneurysm using a gore® viabahn® vbx balloon expandable endoprosthesis.The gore® viabahn® vbx balloon expandable endoprosthesis was implanted to extend the internal iliac component to the right superior gluteal artery.The right inferior gluteal artery was embolized as planned.The type ii endoleak was observed after the device was implanted.Ballooning was performed again and the procedure was concluded without confirmation angiography.On an unknown date, ct imaging showed enlargement of the aneurysm.A type ii or iii endoleak was suspected.On (b)(6) 2023, a reintervention was performed.An intraoperative angiography confirmed the type ii endoleak.There was no type iii endoleak confirmed.In order to treat the type ii endoleak, a branch vessel from the right internal iliac artery and the right superior gluteal artery were embolized.A gore® viabahn® vbx balloon expandable endoprosthesis was implanted in the right internal iliac artery to the right superior gluteal artery to extend the previous implanted gore® viabahn® vbx balloon expandable endoprosthesis.
|